Nuria Juanpere-Rodero Selected Research

Paclitaxel (Taxol)

1/2019

Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nuria Juanpere-Rodero Research Topics

Disease

1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Neoplasms (Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

1	serabelisibIBA 01/2019
1	sapanisertibIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019

Therapy/Procedure

1	Therapeutics 01/2019